Harvest Partners has acquired AxelaCare Holdings, a home infusion therapy provider, from Excellere Partners. AxelaCare’s management team, including CEO Ted Kramm and President Kathee Kramm, will continue to lead the company.
“Healthcare is a key area of interest for Harvest and we have been impressed by AxelaCare’s rapid rise to become the fifth largest provider of immune globulin therapy in the U.S. in just four years,” said Ira Kleinman, Senior Managing Director at Harvest Partners. “The company’s investment in processes, technology and people has led to an efficient, scaleable model with opportunity for continued growth as a larger share of the population seeks access to these vital services.”
AxelaCare is a full-service home infusion therapy provider. Therapies provided range from immune globulin therapy to antibiotics and nutrition therapy for patients across the United States. The company was founded in 2008 and is based in Lenexa, KS (www.axelacare.com).
Senior debt for this transaction was arranged by GE Capital, Ares Capital and BMO Capital Markets. Oaktree Capital Management and Northwestern Mutual Capital provided mezzanine debt financing.
Harvest Partners invests in management buyouts and growth financings. Sectors of interest include business and industrial services, manufacturing and distribution, healthcare, midstream energy, and consumer products and retail sectors. The firm was founded in 1981 and is based in New York (www.harvpart.com).
Excellere Partners invests in middle-market companies with revenues ranging from $20 million to $150 million. Sectors of interest include healthcare, specialty foods, industrial technology and services, business services, and education and training. The firm has $737 million of capital under management and is based in Denver (www.excellerepartners.com).
© 2013 PEPD • Private Equity’s Leading News Magazine • 4-16-13
